Kardigan, Inc.
Status: Publicly traded
Direct answer
Kardigan, Inc. is publicly traded on NASDAQ under the ticker KARD.
Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The...
Can you invest in Kardigan, Inc.?
Yes. Kardigan, Inc. trades publicly on NASDAQ as KARD.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Kardigan, Inc.
Detailed equity research is provided by MarketSnap.